Income Statement Thermo Fisher Scientific Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2024-12-06 pm EST			5-day change	1st Jan Change
529.36 ^USD	+1.63%		-0.05%	-0.27%

Dec. 04	Thermo Fisher Scientific Insider Sold Shares Worth $10,624,559, According to a Recent SEC Filing	MT
Dec. 04	Thermo Fisher Scientific Launches CTS? Detachable Dynabeads? CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	CI

00.QUA_9wU1gocOd7Qxl4OffO27cYXWM4NSMSPx2e6lyM8.CDh82mNqs9dhQdtr7cHeBrTOFrSJXvYIVEaI6NmXq601CFqZN0HI030x-Q

Published financial data: THERMO FISHER SCIENTIFIC INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	25.54B	32.22B	39.21B	44.92B	42.86B
Total Revenues	25.54B	32.22B	39.21B	44.92B	42.86B
Cost of Goods Sold, Total	14.2B	16.21B	19.57B	25.92B	25.74B
Gross Profit	11.34B	16.01B	19.64B	19B	17.11B
Selling General & Admin Expenses, Total	6.08B	6.96B	8B	8.94B	8.38B
R&D Expenses	1B	1.18B	1.41B	1.47B	1.34B
Other Operating Expenses	-	-	3M	-	1M
Other Operating Expenses, Total	7.08B	8.14B	9.41B	10.41B	9.72B
Operating Income	4.26B	7.87B	10.23B	8.59B	7.39B
Interest Expense, Total	-676M	-553M	-536M	-726M	-1.38B
Interest And Investment Income	224M	65M	43M	272M	879M
Net Interest Expenses	-452M	-488M	-493M	-454M	-496M
Income (Loss) On Equity Invest.	-	-	-4M	-172M	-59M
Currency Exchange Gains (Loss)	52M	-81M	162M	102M	-29M
Other Non Operating Income (Expenses)	11M	81M	-161M	-35M	5M
EBT, Excl. Unusual Items	3.87B	7.38B	9.73B	8.03B	6.82B
Restructuring Charges	-26M	-18M	-37M	-95M	-233M
Merger & Related Restructuring Charges	-79M	-81M	-35M	-	-
Gain (Loss) On Sale Of Investments	44M	10M	66M	-161M	-46M
Gain (Loss) On Sale Of Assets	482M	-	-	14M	-
Asset Writedown	-	-34M	-122M	-60M	-219M
Legal Settlements	-	-	-	-	-19M
Other Unusual Items	-223M	-37M	-767M	-63M	-59M
EBT, Incl. Unusual Items	4.07B	7.22B	8.84B	7.66B	6.24B
Income Tax Expense	374M	850M	1.11B	703M	284M
Earnings From Continuing Operations	3.7B	6.38B	7.73B	6.96B	5.96B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	3.7B	6.38B	7.73B	6.96B	5.96B
Minority Interest	-	-	-3M	-10M	40M
Net Income - (IS)	3.7B	6.38B	7.72B	6.95B	6B
Net Income to Common Incl Extra Items	3.7B	6.38B	7.72B	6.95B	6B
Net Income to Common Excl. Extra Items	3.7B	6.38B	7.72B	6.95B	6B
Per Share Items
Net EPS - Basic	9.24	16.1	19.61	17.73	15.53
Basic EPS - Continuing Operations	9.24	16.1	19.61	17.73	15.53
Basic Weighted Average Shares Outstanding	400M	396M	394M	392M	386M
Net EPS - Diluted	9.17	15.96	19.46	17.63	15.45
Diluted EPS - Continuing Operations	9.17	15.96	19.46	17.63	15.45
Diluted Weighted Average Shares Outstanding	403M	399M	397M	394M	388M
Normalized Basic EPS	6.05	11.66	15.43	12.77	11.14
Normalized Diluted EPS	6	11.57	15.31	12.71	11.08
Dividend Per Share	0.76	0.88	1.04	1.2	1.4
Payout Ratio	8.04	5.29	5.11	6.55	8.72
American Depositary Receipts Ratio (ADR)	0.02	0.02	0.02	0.02	0.02
Supplemental Items
EBITDA	6.54B	10.2B	12.82B	11.97B	10.8B
EBITA	5.97B	9.54B	11.99B	10.98B	9.73B
EBIT	4.26B	7.87B	10.23B	8.59B	7.39B
EBITDAR	6.79B	10.47B	13.14B	12.43B	11.27B
Total Revenues (As Reported)	25.54B	32.22B	39.21B	44.92B	42.86B
Effective Tax Rate - (Ratio)	9.19	11.76	12.55	9.17	4.55
Current Domestic Taxes	329M	696M	606M	1.07B	378M
Current Foreign Taxes	544M	423M	1.15B	633M	1.21B
Total Current Taxes	873M	1.12B	1.75B	1.7B	1.58B
Deferred Domestic Taxes	-247M	-251M	-246M	-683M	-653M
Deferred Foreign Taxes	-252M	-18M	-399M	-314M	-647M
Total Deferred Taxes	-499M	-269M	-645M	-997M	-1.3B
Normalized Net Income	2.42B	4.62B	6.08B	5.01B	4.3B
Non-Cash Pension Expense	-5M	10M	-6M	-16M	-5M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Research And Development Expense From Footnotes	1B	1.18B	1.41B	1.47B	1.34B
Net Rental Expense, Total	249M	273M	320M	460M	470M
Imputed Operating Lease Interest Expense	71.58M	58.78M	46.57M	73.7M	142M
Imputed Operating Lease Depreciation	177M	214M	273M	386M	328M
Stock-Based Comp., Other (Total)	181M	196M	230M	307M	278M
Total Stock-Based Compensation	181M	196M	230M	307M	278M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	2.4B	10.32B	4.48B	8.52B	8.08B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	2.4B	10.32B	4.48B	8.52B	8.08B
Accounts Receivable, Total	4.95B	6.47B	8.94B	9.43B	9.66B
Other Receivables	-	-	-	-	-
Total Receivables	4.95B	6.47B	8.94B	9.43B	9.66B
Inventory	3.37B	4.03B	5.05B	5.63B	5.09B
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	21M	10M	13M	12M	6M
Other Current Assets, Total	1.15B	1.12B	1.63B	1.63B	1.75B
Total Current Assets	11.89B	21.96B	20.11B	25.23B	24.59B
Gross Property Plant And Equipment	8.46B	10.35B	14.12B	15.86B	17.08B
Accumulated Depreciation	-3.02B	-3.66B	-4.26B	-4.99B	-6.08B
Net Property Plant And Equipment	5.45B	6.69B	9.86B	10.87B	11B
Long-term Investments	67M	53M	63M	154M	45M
Goodwill	25.71B	26.04B	41.92B	41.2B	44.02B
Other Intangibles, Total	14.01B	12.68B	20.11B	17.48B	16.71B
Accounts Receivable Long-Term	17M	11M	9M	7M	4M
Other Long-Term Assets, Total	1.23B	1.62B	3.04B	2.22B	2.36B
Total Assets	58.38B	69.05B	95.12B	97.15B	98.73B
Liabilities
Accounts Payable, Total	1.92B	2.18B	2.87B	3.38B	2.87B
Accrued Expenses, Total	2.38B	3.84B	5.09B	5.12B	4.52B
Short-term Borrowings	-	-	2.52B	310M	-
Current Portion of Long-Term Debt	673M	2.63B	-	5.26B	3.6B
Current Portion of Leases	170M	184M	281M	283M	268M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	916M	1.27B	2.66B	2.6B	2.69B
Other Current Liabilities	138M	207M	18M	57M	63M
Total Current Liabilities	6.2B	10.3B	13.44B	17.01B	14.01B
Long-Term Debt	17.08B	19.15B	32.15B	28.8B	31.41B
Long-Term Leases	578M	626M	1.39B	1.51B	1.43B
Unearned Revenue Non Current	594M	763M	1.24B	1.18B	1.5B
Pension & Other Post Retirement Benefits	552M	589M	504M	323M	383M
Deferred Tax Liability Non Current	2.19B	1.79B	3.84B	2.85B	1.92B
Other Non Current Liabilities	1.51B	1.32B	1.6B	1.34B	1.23B
Total Liabilities	28.71B	34.54B	54.15B	53.01B	51.88B
Common Stock, Total	434M	437M	439M	441M	442M
Additional Paid In Capital	15.06B	15.58B	16.17B	16.74B	17.29B
Retained Earnings	22.09B	28.12B	35.43B	41.91B	47.36B
Treasury Stock	-5.24B	-6.82B	-8.92B	-12.02B	-15.13B
Comprehensive Income and Other	-2.68B	-2.81B	-2.33B	-3.1B	-3.22B
Total Common Equity	29.68B	34.51B	40.79B	43.98B	46.74B
Minority Interest	-	-	184M	170M	107M
Total Equity	29.68B	34.51B	40.98B	44.15B	46.84B
Total Liabilities And Equity	58.38B	69.05B	95.12B	97.15B	98.73B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	399M	394M	391M	385M	381M
ECS Total Common Shares Outstanding	399M	397M	394M	391M	387M
Book Value / Share	74.42	86.99	103.42	112.62	120.87
Tangible Book Value	-10.05B	-4.22B	-21.24B	-14.7B	-13.99B
Tangible Book Value Per Share	-25.21	-10.64	-53.86	-37.63	-36.19
Total Debt	18.5B	22.59B	36.34B	36.16B	36.71B
Net Debt	16.1B	12.27B	31.86B	27.63B	28.63B
Debt Equivalent of Unfunded Proj. Benefit Obligation	418M	361M	284M	259M	335M
Debt Equivalent Oper. Leases	1.99B	2.18B	2.56B	3.68B	3.76B
Minority Interest, Total (Incl. Fin. Div)	-	-	184M	170M	107M
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	-39M	-49M	-	-	-
Inventories - Raw Materials, Total	971M	1.3B	1.92B	2.4B	2.06B
Inventories - Work In Process, Total	517M	540M	676M	660M	705M
Inventories - Finished Goods, Total	1.88B	2.18B	2.45B	2.57B	2.33B
Land - (BS)	396M	410M	431M	454M	458M
Buildings, Total	1.87B	2.19B	2.58B	3.15B	3.59B
Machinery, Total	5.5B	6.98B	9.59B	7.97B	9.24B
Full Time Employees	75K	80K	130K	130K	122K
Accumulated Allowance for Doubtful Accounts (Supple)	102M	135M	150M	189M	193M
Order Backlog	7.77B	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	3.7B	6.38B	7.72B	6.95B	6B
Depreciation & Amortization - CF	564M	658M	831M	986M	1.07B
Amortization of Goodwill and Intangible Assets - (CF)	1.71B	1.67B	1.76B	2.4B	2.34B
Depreciation & Amortization, Total	2.28B	2.32B	2.59B	3.38B	3.41B
(Gain) Loss From Sale Of Asset	-482M	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	181M	196M	230M	307M	278M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-34M	-212M	313M	-435M	-736M
Change In Accounts Receivable	-225M	-1.3B	-204M	-430M	209M
Change In Inventories	-458M	-508M	-1.06B	-825M	598M
Change In Accounts Payable	266M	59M	479M	648M	-500M
Change in Other Net Operating Assets	-248M	1.36B	-758M	-442M	-844M
Cash from Operations	4.97B	8.29B	9.31B	9.15B	8.41B
Capital Expenditure	-926M	-1.47B	-2.52B	-2.24B	-1.48B
Sale of Property, Plant, and Equipment	36M	8M	20M	24M	87M
Cash Acquisitions	-1.84B	-38M	-19.4B	-39M	-3.66B
Divestitures	1.13B	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	118M	-6M	-34M	99M	-90M
Cash from Investing	-1.49B	-1.51B	-21.93B	-2.16B	-5.14B
Short Term Debt Issued, Total	2.78B	383M	2.51B	1.53B	1.62B
Long-Term Debt Issued, Total	5.64B	3.46B	18.14B	3.19B	5.94B
Total Debt Issued	8.42B	3.85B	20.65B	4.72B	7.56B
Short Term Debt Repaid, Total	-3.46B	-387M	-	-3.69B	-1.94B
Long-Term Debt Repaid, Total	-6.36B	-713M	-11.74B	-375M	-5.78B
Total Debt Repaid	-9.82B	-1.1B	-11.74B	-4.06B	-7.72B
Issuance of Common Stock	153M	196M	156M	-	-
Repurchase of Common Stock	-1.5B	-1.5B	-2B	-3B	-3B
Common Dividends Paid	-297M	-337M	-395M	-455M	-523M
Common & Preferred Stock Dividends Paid	-297M	-337M	-395M	-455M	-523M
Other Financing Activities, Total	-69M	-147M	-91M	-9M	56M
Cash from Financing	-3.12B	959M	6.58B	-2.81B	-3.62B
Foreign Exchange Rate Adjustments	-63M	176M	194M	-139M	-82M
Net Change in Cash	305M	7.91B	-5.84B	4.05B	-440M
Supplemental Items
Cash Interest Paid	790M	471M	555M	667M	1.38B
Cash Income Tax Paid (Refund)	896M	1.32B	2.18B	1.23B	1.48B
Levered Free Cash Flow	3.28B	5.62B	5.49B	5.82B	5.14B
Unlevered Free Cash Flow	3.7B	5.97B	5.83B	6.27B	6B
Change In Net Working Capital	494M	0	863M	543M	826M
Net Debt Issued / Repaid	-1.4B	2.75B	8.91B	654M	-155M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	4.65	7.72	7.79	5.58	4.72
Return on Total Capital	5.61	9.35	9.51	6.81	5.64
Return On Equity %	12.91	19.87	20.47	16.35	13.09
Return on Common Equity	12.91	19.87	20.52	16.4	13.22
Margin Analysis
Gross Profit Margin %	44.41	49.69	50.08	42.3	39.93
SG&A Margin	23.8	21.59	20.4	19.9	19.56
EBITDA Margin %	25.6	31.65	32.69	26.65	25.2
EBITA Margin %	23.39	29.61	30.58	24.45	22.71
EBIT Margin %	16.68	24.44	26.08	19.12	17.25
Income From Continuing Operations Margin %	14.47	19.79	19.71	15.5	13.9
Net Income Margin %	14.47	19.79	19.7	15.47	13.99
Net Avail. For Common Margin %	14.47	19.79	19.7	15.47	13.99
Normalized Net Income Margin	9.47	14.33	15.5	11.15	10.03
Levered Free Cash Flow Margin	12.84	17.45	14.01	12.95	12
Unlevered Free Cash Flow Margin	14.49	18.52	14.86	13.96	14
Asset Turnover
Asset Turnover	0.45	0.51	0.48	0.47	0.44
Fixed Assets Turnover	5.31	5.31	4.74	4.33	3.92
Receivables Turnover (Average Receivables)	5.35	5.64	5.09	4.89	4.49
Inventory Turnover (Average Inventory)	4.45	4.38	4.31	4.85	4.8
Short Term Liquidity
Current Ratio	1.92	2.13	1.5	1.48	1.75
Quick Ratio	1.19	1.63	1	1.06	1.27
Operating Cash Flow to Current Liabilities	0.8	0.8	0.69	0.54	0.6
Days Sales Outstanding (Average Receivables)	68.21	64.89	71.76	74.65	81.3
Days Outstanding Inventory (Average Inventory)